Tofacitinib Ameliorates Lipopolysaccharide-Induced Acute Kidney Injury by Blocking the JAK-STAT1/STAT3 Signaling Pathway.

Autor: Yun, Yang1 (AUTHOR), Chen, Jingyu1 (AUTHOR), Wang, Xuejiao1 (AUTHOR), Li, Yingzhuo1 (AUTHOR), Hu, Zhifan1 (AUTHOR), Yang, Pingting2 (AUTHOR), Qin, Ling1 (AUTHOR)
Zdroj: BioMed Research International. 1/15/2021, p1-9. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje